AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kwang Dong Pharmaceutical Co., Ltd.

₩6370 +$520.00 (+8.89%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩6380
Day Range
₩6330₩6440
Year Range
₩5150₩12800
Market Cap
316.34B
AVG Volume
193.68K
Trailing/Forward PE
12.6/12.09
PEG ratio
-9.62
Dividend Yield
1.57%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0500B1T1.5T2T2016201720182019202020212022202320242025
009290.KS Revenue (KRW) by year
PeriodRevenue (KRW)
20251.66T
20241.64T
20231.51T
20221.43T
20211.34T
20201.24T
20191.24T
20181.18T
20171.14T
20161.06T
Net Income (KRW)
020B40B60B2016201720182019202020212022202320242025
009290.KS Net Income (KRW) by year
PeriodNet Income (KRW)
202520.97B
202440.48B
202336.97B
202224.17B
202124.02B
202045.37B
201923.06B
201822.35B
201723.2B
201628.06B
Operating Income (KRW)
020B40B60B2016201720182019202020212022202320242025
009290.KS Operating Income (KRW) by year
PeriodOperating Income (KRW)
202531.05B
202430.1B
202342.08B
202241.89B
202144.94B
202046.59B
201941.8B
201833.94B
201735.74B
201644.39B
EBITDA (KRW)
020B40B60B80B2016201720182019202020212022202320242025
009290.KS EBITDA (KRW) by year
PeriodEBITDA (KRW)
202548.54B
202468.89B
202367.44B
202254.51B
202151.02B
202066.3B
201961.26B
201851.31B
201751.08B
201658.77B
Cash Flows (KRW)
-100B-50B050B100B2016201720182019202020212022202320242025
009290.KS Cash Flows (KRW) by year
PeriodCash Flows (KRW)
202555.18B
2024-88.1B
2023-46.89B
202236.78B
202130.49B
202017.53B
201916.6B
201833.95B
20175.37B
201610.66B
EPS (KRW)
0500100015002016201720182019202020212022202320242025
009290.KS EPS (KRW) by year
PeriodEPS (KRW)
2025521.69
20241010.06
2023910.72
2022588.45
2021591.43
20201118.71
2019581.18
2018551.05
2017571.79
2016691.2
Expenses (KRW)
0100B200B300BR&DSG&ACapex2016201720182019202020212022202320242025
009290.KS Expenses (KRW) by year
PeriodExpenses (KRW)
2025215.84B
2024285.43B
2023223.77B
2022176.63B
2021170.01B
2020135.51B
2019146.86B
2018144.69B
2017152.68B
2016148.86B
Cash & Debt (KRW)
0100B200B300B400BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
009290.KS Cash & Debt (KRW) by year
PeriodCash & Debt (KRW)
2025227.69B
2024165.45B
2023206.18B
2022208.63B
2021187.7B
2020149.27B
2019112B
2018120.77B
201799.78B
201695.38B
Debt ratios
-0.5-0.2500.250.520182019202020212022202320242025
009290.KS Debt ratios by year
PeriodDebt ratios
20250.36
20240.5
20230.12
2022-0.3
2021-0.24
2020-0.17
20190
2018-0.09
Margins
0%10%20%30%2016201720182019202020212022202320242025
009290.KS Margins by year
PeriodMargins
202517.67%
202418.16%
202319.72%
202219.7%
202120.49%
202020.72%
201920.89%
201820.47%
201721.65%
201623.45%
Return on Capital
0%2.5%5%7.5%10%2016201720182019202020212022202320242025
009290.KS Return on Capital by year
PeriodReturn on Capital
20252.93%
20246.55%
20236.29%
20224.42%
20214.56%
20209.03%
20195.15%
20185.19%
20175.57%
20167.02%
Shares Outstanding
020M40M60M2016201720182019202020212022202320242025
009290.KS Shares Outstanding by year
PeriodShares Outstanding
202548.18M
202439.9M
202340.08M
202241.08M
202140.89M
202041.08M
201939.42M
201840.57M
201740.51M
201640.41M
Dividends (KRW)
02550751002016201720182019202020212022202320252026
009290.KS Dividends (KRW) by year
PeriodDividends (KRW)
2026100
2025100
2023100
2022100
2021100
2020100
201980
201880
201780
201680
Book Value Per Share (KRW)
050001000015000200002016201720182019202020212022202320242025
009290.KS Book Value Per Share (KRW) by year
PeriodBook Value Per Share (KRW)
202514834.4
202415494.65
202314671.47
202213316.41
202112892.95
202012224.3
201911351.72
201810618.81
201710275.4
20169891.32
Total Assets (KRW)
0500B1T1.5T2016201720182019202020212022202320242025
009290.KS Total Assets (KRW) by year
PeriodTotal Assets (KRW)
20251.32T
20241.17T
20231.08T
2022932.02B
2021883.85B
2020830.64B
2019792.78B
2018732.06B
2017722.7B
2016679.78B
PE Ratio
5101520med 8.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS PE Ratio by year
PeriodPE Ratio
Sep 2614.65
Sep 2614.56
Sep 2614.56
Aug 2615.04
Aug 2613.67
Aug 2614.52
Aug 2614.84
Jul 2613.9
Jul 2613.62
Jul 2614.01
Jul 2614.45
Jul 2613.83
Jun 2612.11
Jun 2613.26
Jun 2614.66
Jun 2614.41
May 2615.74
May 2617.37
May 2617.3
May 2618.45
Apr 2619
Apr 2619.37
Apr 2619.44
Apr 2619.44
Apr 2619.1
Mar 2611.94
Mar 2612.41
Mar 2612.12
Mar 2611.86
Feb 2612.82
Feb 2613.98
Feb 268.28
Feb 268.25
Jan 268.1
Jan 267.89
Jan 267.8
Jan 267.82
Jan 267.86
Dec 258.76
Dec 258.68
Dec 258.9
Dec 258.81
Nov 258.71
Nov 258.64
Nov 258.7
Nov 258.18
Oct 258.28
Oct 258.26
Oct 258.15
Oct 258.29
Oct 258.47
Sep 258.91
Sep 258.96
Sep 259.26
Sep 259.2
Aug 259.2
Aug 259.09
Aug 259.25
Aug 259.2
Aug 259.05
Jul 259.29
Jul 259.61
Jul 259.87
Jul 259.03
Jun 255.79
Jun 255.65
Jun 255.66
Jun 255.58
May 255.46
May 255.36
May 255.39
May 255.44
May 255.41
Apr 255.43
Apr 255.29
Apr 255.18
Apr 255.29
Mar 256.44
Mar 256.51
Mar 256.54
Mar 256.6
Feb 256.65
Feb 256.76
Feb 256.42
Feb 256.4
Jan 256.47
Jan 256.47
Jan 256.61
Jan 256.76
Jan 256.66
Dec 246.64
Dec 246.74
Dec 246.71
Dec 246.31
Nov 246.61
Nov 246.58
Nov 246.25
Nov 246.64
Nov 246.5
Oct 246.6
Free Cash Flow Yield
-60%-40%-20%0%20%40%med -2.99%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 2610.48%
Sep 2610.55%
Sep 2610.55%
Aug 2610.21%
Aug 2611.24%
Aug 2610.58%
Aug 2610.35%
Jul 2611.05%
Jul 2611.28%
Jul 2610.96%
Jul 2610.63%
Jul 2611.11%
Jun 2621.73%
Jun 2619.85%
Jun 2617.95%
Jun 2618.27%
May 2616.72%
May 2615.15%
May 2615.21%
May 2614.26%
Apr 2613.85%
Apr 2613.59%
Apr 2613.54%
Apr 2613.54%
Apr 2613.78%
Mar 261.6%
Mar 261.54%
Mar 261.58%
Mar 261.62%
Feb 261.49%
Feb 261.37%
Feb 262.31%
Feb 262.32%
Jan 262.36%
Jan 262.43%
Jan 262.46%
Jan 262.45%
Jan 262.44%
Dec 25-2.79%
Dec 25-2.81%
Dec 25-2.75%
Dec 25-2.77%
Nov 25-2.8%
Nov 25-2.83%
Nov 25-2.81%
Nov 25-2.99%
Oct 25-2.95%
Oct 25-2.96%
Oct 25-3%
Oct 25-2.95%
Oct 25-2.89%
Sep 25-21.57%
Sep 25-21.46%
Sep 25-20.76%
Sep 25-20.9%
Aug 25-20.9%
Aug 25-21.14%
Aug 25-20.8%
Aug 25-20.9%
Aug 25-21.25%
Jul 25-20.69%
Jul 25-20.01%
Jul 25-19.49%
Jul 25-21.28%
Jun 25-37.61%
Jun 25-38.53%
Jun 25-38.46%
Jun 25-39.01%
May 25-39.85%
May 25-40.58%
May 25-40.36%
May 25-40%
May 25-40.22%
Apr 25-40.07%
Apr 25-41.11%
Apr 25-41.97%
Apr 25-41.11%
Mar 25-34.97%
Mar 25-34.59%
Mar 25-34.41%
Mar 25-34.1%
Feb 25-33.85%
Feb 25-33.32%
Feb 25-35.04%
Feb 25-35.17%
Jan 25-34.78%
Jan 25-34.78%
Jan 25-34.04%
Jan 25-33.32%
Jan 25-33.79%
Dec 24-46.88%
Dec 24-46.14%
Dec 24-46.38%
Dec 24-49.34%
Nov 24-47.05%
Nov 24-47.3%
Nov 24-49.81%
Nov 24-46.88%
Nov 24-47.9%
Oct 24-47.13%
Price to Sales
0.10.150.20.25med 0.15Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS Price to Sales by year
PeriodPrice to Sales
Sep 260.19
Sep 260.19
Sep 260.19
Aug 260.19
Aug 260.17
Aug 260.19
Aug 260.19
Jul 260.18
Jul 260.17
Jul 260.18
Jul 260.18
Jul 260.18
Jun 260.15
Jun 260.17
Jun 260.19
Jun 260.18
May 260.2
May 260.22
May 260.22
May 260.23
Apr 260.24
Apr 260.24
Apr 260.25
Apr 260.25
Apr 260.24
Mar 260.21
Mar 260.22
Mar 260.22
Mar 260.21
Feb 260.23
Feb 260.25
Feb 260.15
Feb 260.15
Jan 260.14
Jan 260.14
Jan 260.14
Jan 260.14
Jan 260.14
Dec 250.15
Dec 250.15
Dec 250.15
Dec 250.15
Nov 250.15
Nov 250.15
Nov 250.15
Nov 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Sep 250.14
Sep 250.15
Sep 250.15
Sep 250.15
Aug 250.15
Aug 250.15
Aug 250.15
Aug 250.15
Aug 250.15
Jul 250.15
Jul 250.16
Jul 250.16
Jul 250.15
Jun 250.14
Jun 250.14
Jun 250.14
Jun 250.14
May 250.13
May 250.13
May 250.13
May 250.13
May 250.13
Apr 250.13
Apr 250.13
Apr 250.13
Apr 250.13
Mar 250.13
Mar 250.13
Mar 250.14
Mar 250.14
Feb 250.14
Feb 250.14
Feb 250.13
Feb 250.13
Jan 250.13
Jan 250.13
Jan 250.14
Jan 250.14
Jan 250.14
Dec 240.14
Dec 240.14
Dec 240.14
Dec 240.13
Nov 240.14
Nov 240.14
Nov 240.13
Nov 240.14
Nov 240.14
Oct 240.14
EV/EBITDA
24681012med 4.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS EV/EBITDA by year
PeriodEV/EBITDA
Sep 268.05
Sep 268.01
Sep 268.01
Aug 268.21
Aug 267.66
Aug 268
Aug 268.12
Jul 267.75
Jul 267.64
Jul 267.79
Jul 267.97
Jul 267.72
Jun 266.99
Jun 267.49
Jun 268.09
Jun 267.98
May 268.56
May 269.26
May 269.23
May 269.73
Apr 269.97
Apr 2610.13
Apr 2610.16
Apr 2610.16
Apr 2610.01
Mar 263.62
Mar 263.74
Mar 263.66
Mar 263.6
Feb 263.84
Feb 264.13
Feb 262.7
Feb 262.7
Jan 262.66
Jan 262.61
Jan 262.58
Jan 262.59
Jan 262.6
Dec 252.94
Dec 252.92
Dec 252.98
Dec 252.95
Nov 252.93
Nov 252.91
Nov 252.93
Nov 252.8
Oct 252.83
Oct 252.82
Oct 252.79
Oct 252.83
Oct 252.87
Sep 257.49
Sep 257.51
Sep 257.69
Sep 257.66
Aug 257.66
Aug 257.59
Aug 257.68
Aug 257.66
Aug 257.57
Jul 257.71
Jul 257.9
Jul 258.05
Jul 257.56
Jun 255.15
Jun 255.07
Jun 255.07
Jun 255.03
May 254.96
May 254.9
May 254.92
May 254.95
May 254.93
Apr 254.94
Apr 254.86
Apr 254.8
Apr 254.86
Mar 253.98
Mar 254.01
Mar 254.03
Mar 254.05
Feb 254.08
Feb 254.12
Feb 253.97
Feb 253.96
Jan 253.99
Jan 253.99
Jan 254.06
Jan 254.12
Jan 254.08
Dec 244.77
Dec 244.82
Dec 244.8
Dec 244.61
Nov 244.76
Nov 244.74
Nov 244.59
Nov 244.77
Nov 244.7
Oct 244.75
Price/Operating Cashflow
0102030med 5.52Sep 23Jan 24Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 266.07
Sep 266.03
Sep 266.03
Aug 266.23
Aug 265.66
Aug 266.01
Aug 266.14
Jul 265.75
Jul 265.64
Jul 265.8
Jul 265.98
Jul 265.72
Jun 263.08
Jun 263.38
Jun 263.73
Jun 263.67
May 264.01
May 264.42
May 264.41
May 264.7
Apr 264.84
Apr 264.93
Apr 264.95
Apr 264.95
Apr 264.86
Mar 266.06
Mar 266.3
Mar 266.16
Mar 266.02
Feb 266.51
Feb 267.1
Feb 264.21
Feb 264.19
Jan 264.12
Jan 264.01
Jan 263.96
Jan 263.97
Jan 263.99
Dec 253.97
Dec 253.94
Dec 254.04
Dec 254
Nov 253.95
Nov 253.92
Nov 253.94
Nov 253.71
Oct 253.75
Oct 253.75
Oct 253.69
Oct 253.76
Oct 253.84
Sep 258.25
Sep 258.29
Sep 258.57
Sep 258.51
Aug 258.51
Aug 258.42
Aug 258.56
Aug 258.51
Aug 258.37
Jul 258.6
Jul 258.89
Jul 259.13
Jul 258.36
Mar 2427.81
Mar 2429.68
Mar 2427.08
Mar 2427.73
Feb 2427.77
Feb 2428.77
Feb 2429.42
Feb 2428.77
Feb 2428.65
Jan 2427.12
Jan 2428
Jan 2427.01
Jan 2427.77
Dec 235.66
Dec 235.72
Dec 235.62
Dec 235.87
Dec 235.43
Nov 235.37
Nov 235.4
Nov 235.27
Nov 235.8
Oct 235.33
Oct 235.06
Oct 235.71
Oct 234.52
Sep 233.88
Sep 233.94
Sep 234.12
Sep 234.16
Sep 234.12
Aug 234.22
Aug 234.08
Aug 234.44
Aug 234.3
Jul 234.21
Price to Book
0.30.40.50.60.7med 0.38Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
009290.KS Price to Book by year
PeriodPrice to Book
Sep 260.44
Sep 260.44
Sep 260.44
Aug 260.45
Aug 260.41
Aug 260.44
Aug 260.45
Jul 260.42
Jul 260.41
Jul 260.42
Jul 260.44
Jul 260.42
Jun 260.36
Jun 260.39
Jun 260.43
Jun 260.42
May 260.46
May 260.51
May 260.51
May 260.54
Apr 260.56
Apr 260.57
Apr 260.57
Apr 260.57
Apr 260.56
Mar 260.55
Mar 260.57
Mar 260.56
Mar 260.55
Feb 260.59
Feb 260.65
Feb 260.38
Feb 260.38
Jan 260.37
Jan 260.36
Jan 260.36
Jan 260.36
Jan 260.36
Dec 250.38
Dec 250.38
Dec 250.39
Dec 250.39
Nov 250.38
Nov 250.38
Nov 250.38
Nov 250.36
Oct 250.36
Oct 250.36
Oct 250.36
Oct 250.36
Oct 250.37
Sep 250.38
Sep 250.38
Sep 250.39
Sep 250.39
Aug 250.39
Aug 250.38
Aug 250.39
Aug 250.39
Aug 250.38
Jul 250.39
Jul 250.41
Jul 250.42
Jul 250.38
Jun 250.38
Jun 250.37
Jun 250.37
Jun 250.37
May 250.36
May 250.35
May 250.35
May 250.36
May 250.35
Apr 250.36
Apr 250.35
Apr 250.34
Apr 250.35
Mar 250.35
Mar 250.36
Mar 250.36
Mar 250.36
Feb 250.37
Feb 250.37
Feb 250.35
Feb 250.35
Jan 250.36
Jan 250.36
Jan 250.36
Jan 250.37
Jan 250.37
Dec 240.37
Dec 240.38
Dec 240.37
Dec 240.35
Nov 240.37
Nov 240.37
Nov 240.35
Nov 240.37
Nov 240.36
Oct 240.37
Kwang Dong Pharmaceutical Co., Ltd.
009290.KS
Stockpicker

Video analysis: 009290.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.